Skip to main content

Month: December 2020

T6391 Display Driver IC Test System Cumulative Shipments Reach 1000 Units

TOKYO, Dec. 11, 2020 (GLOBE NEWSWIRE) — Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) has announced that cumulative shipments of the company’s T6391 display driver test system have reached 1,000 units.Since its introduction in 2000, the T6300 series has been adopted by customers all over the world and has established overwhelming dominance in the display driver IC test market. The latest model, the T6391, has excellent compatibility with previous models, supports next-generation I/F, and provides leading-edge test solutions that address the technological trends of next-generation display driver ICs such as multi-pin and multi-functionality. As smartphones become more sophisticated in the future, displays with higher image quality, such as 4K and 8K, will be introduced, and interfaces will...

Continue reading

Athenex 發表口服紫杉醇和 Encequidar 用於轉移性乳癌患者的最新第 3 期存活率和耐受性數據

在 SABCS 發表的數據表明口服紫杉醇和 encequidar(口服紫杉醇)的益處與靜脈注射 (IV) 紫杉醇 (IVP) 相比,前者在疾病無惡化存活期 (PFS) 及整體存活率 (OS) 方面均支持更高的主要終點的整體緩解率 (ORR)。在意向治療 (ITT) 人群中,口服紫杉醇與靜脈注射紫杉醇相比,顯示出對疾病無惡化存活期的益處,而且在整體存活率上顯示優勢。口服紫杉醇顯示疾病無惡化存活期中位數為 8.4 個月,對比 7.4 個月,風險比率 (HR) 為 0.768 (95% CI:0.584,1.01),p=0.046。口服紫杉醇的整體存活率中位數為 22.7 個月,對比 16.5 個月,風險比率為 0.794 (95% CI:0.607,1.037),p=0.082。在預先指定的改良意向治療 (mITT) 人群中,口服紫杉醇與靜脈注射紫杉醇相比,在疾病無惡化存活期和整體存活率上均顯示出優勢。口服紫杉醇的疾病無惡化存活期中位數為 8.4 個月,對比 7.4 個月,風險比率為 0.739 (95% CI:0.561,0.974),p=0.023,整體存活率中位數為 23.3 個月,對比 16.3 個月,風險比率為 0.735 (95% CI:0.556,0.972),p=0.026。其他發表的數據突顯良好的耐受性,衡量方法為持續的神經病變低發生率及可管理的腸胃副作用。紐約州水牛城, Dec. 11, 2020 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX) 是一家致力研究、開發和商業化下一代癌症治療和相關疾病新療法的全球生物製藥公司,今天宣佈提供最新的第 3 期疾病無惡化存活期 (PFS) 和整體存活率 (OS) 數據,其用於轉移性乳癌患者的口服紫杉醇與靜脈注射紫杉醇 (IVP) 相比,顯示在療效和耐受性方面的臨床益處。這些結果進一步支持口服紫杉醇在增加整體緩解率 (ORR) 中觀察到的優勢。這些數據已在...

Continue reading

LEADING EDGE MATERIALS COMMISSIONS LIFE CYCLE ANALYSIS ON WOXNA GRAPHITE PROJECT

Vancouver, December 10, 2020 – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) is pleased to announce that it has recently commissioned Minviro Ltd. (“Minviro”), a London based globally recognized life cycle assessment (“LCA”) consultancy, to build an LCA model and deliver an LCA report for the Woxna Graphite project.On December 10th, the European Commission proposed new legislation to ensure that batteries placed on the EU market will be sustainable along their entire life cycle, including mandatory requirements to declare their associated carbon footprinti. Earlier in 2020 Minviro published a white paperii concluding that existing battery LCA studies might have underestimated the CO2 intensity of production by up to six times for both natural and synthetic...

Continue reading

Unibail-Rodamco-Westfield’s ambitious carbon reduction targets recognized by the Science Based Targets initiative (SBTi)

 Paris, Amsterdam, December 11, 2020Press releaseUnibail-Rodamco-Westfield’s ambitious carbon reduction targets recognized by the Science Based Targets initiative (SBTi)Unibail-Rodamco-Westfield (URW) is pleased to announce the greenhouse gas (GHG) emissions reduction targets of its “Better Places 2030” CSR strategy have been approved by the Science Based Targets initiative (SBTi) as consistent with levels required to meet the goals of the Paris Agreement: URW’s targets covering emissions from the Group’s operations (scopes 1 and 2) are consistent with reductions required to maintain global warming under 1.5°C, the most ambitious goal of the Paris Agreement.URW’s emissions target pertaining to its value chain (scope 3) meet the SBTi’s criteria for ambitious value chain goals, corresponding to the current best practices.The SBTi is a collaboration...

Continue reading

Hofseth Biocare ASA: HBC and Tenet Partners initiate a long-term collaboration to build a global brand and launch HBC own branded consumer health products

HBC has today started a long-term collaboration with world leading brand innovation and marketing consultancy company, Tenet Partners, based in New York, USA. Their goal is to build a consumer brand for HBC’s line of salmon-based products. Tenet Partners have an impressive and long track record in building powerful brands with a clear vision that motivate connections with consumers. They have experience across a multitude of sectors with particular focus on healthcare and consumer product sectors, making them an excellent partner for HBC. Within healthcare, Tenet’s clients include Amgen, J&J, Pfizer, Catalent and NPS Pharma and in consumer products they have worked with Colgate-Palmolive, Kraft, PepsiCo and even WellPet, a natural pet food brands owner.The collaboration with Tenet will enable HBC to accelerate the development of...

Continue reading

Panostaja Oyj’s Financial Statement Bulletin 1.11.2019-31.10.2020

Panostaja Oyj      Financial Statement Bulletin                    December 11, 2020 at 10.00 a.m.The coronavirus weakens net sales but streamlining measures support the resultAugust 1, 2020-October 31, 2020 (3 months) Net sales increased in two of the seven segments. Net sales for the Group as a whole weakened by 15% to MEUR 40.7 (MEUR 47.8).Net sales improved in two of the seven segments. The entire Group’s EBIT declined from the reference period, standing at MEUR -0.7 (MEUR 1.7). The profit/loss for the review period is encumbered by the MEUR 3.3 goodwill impairment loss of the Carrot segment. The reference period’s profit/loss includes a cost provision of MEUR 1.3.Grano’s net sales for the review period declined by 13% from the reference period in the previous year. EBIT strengthened to MEUR 3.2 (MEUR 1.8).Earnings per share (undiluted)...

Continue reading

Panostaja Oyj:n tilinpäätöstiedote 1.11.2019-31.10.2020

Panostaja Oyj        Tilinpäätöstiedote      11.12.2020 klo 10.00Korona heikensi tilikauden liikevaihtoa, mutta säästötoimet tukivat tulosta1.8.2020-31.10.2020 (3 kk) Liikevaihto kasvoi kahdessa seitsemästä sijoituskohteesta. Kokonaisuutena konsernin liikevaihto heikkeni 15 % ja oli 40,7 milj. euroa (47,8 milj. euroa).Liikevoitto parani kahdessa seitsemästä sijoituskohteesta. Koko konsernin liikevoitto laski vertailukaudesta ollen -0,7 milj. euroa (1,7 milj. euroa). Katsauskauden tulosta rasittaa Carrot –segmentistä tehty 3,3 milj. euron liikearvon arvonalentumistappio. Vertailukauden tulokseen sisältyy 1,3 milj.euron kuluvaraukset. Granon katsauskauden liikevaihto heikkeni 13 % edellisvuoden vertailukaudesta. Liikevoitto vahvistui ollen 3,2 milj. euroa (1,8 milj. euroa).Tulos/osake (laimentamaton) oli -4,7 senttiä (-0,5 senttiä).             1.11.2019-31.10.2020...

Continue reading

Havila Shipping ASA: Termination of charterparty with DeepOcean for Havila Phoenix

The subsea vessel Havila Phoenix has since 2013 served DeepOcen, under a charterparty with firm period until May 2023 with further options.On the 18 November 2020 Havila Shipping received a letter from DeepOcean containing information regarding their intension to seek protection under British law for wind up of the UK based activities, including the company that has chartered Havila Phoenix.After having finalized the project Havila Phoenix was engaged in at receipt of the letter mentioned, Havila Shipping ASA has received no instructions regarding further use of the vessel.DeepOcean has, as a result of their activities, or lack of activities, ended up in breach of contractual obligations, including payment default.Havila Shipping ASA, today has, as a consequence, terminated the charterparty.  Further, Havila Shipping ASA has requested...

Continue reading

Havila Shipping ASA: Terminering av kontrakten med DeepOcean for Havila Phoenix

Subseafartøyet Havila Phoenix har vært på oppdrag for DeepOcean siden 2013 under en kontrakt med fast periode fram til mai 2023 med opsjoner for forlengelse.DeepOcean varslet i brev datert 18.11.20 til Havila Shipping ASA at DeepOcean har intensjon om å søke beskyttelse under engelsk lov for avvikling av den engelske delen av virksomheten, og dette omfatter også det selskapet som har kontrahert Havila Phoenix.Etter at Havila Phoenix avsluttet prosjektet fartøyet arbeidet på da varselet ble mottatt, har Havila Shipping ASA ikke mottatt ytterligere instruksjoner for bruk av fartøyet.DeepOcean er i kraft av sine handlinger, eller som følge av mangel på handlinger, i brudd med bestemmelser i certepartiet, herunder betalingsmislighold.Havila Shipping ASA  har i dag tatt konsekvensen av at DeepOcean er i brudd med bestemmelser i certepartiet...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.